HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1766107Erstellt: 26. Oktober 2026
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid → HCID 178512911, Verbindung
https://huagongshe.com/reaction/1766107
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | HCID 3383 | — |
| Edukt | Norleucine, (+-)- | HCID 9475 | — |
| Edukt | Fluorescein 5-isothiocyanate | HCID 18730 | — |
| Edukt | Diisopropylethylamine | HCID 81531 | — |
| Edukt | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Edukt | Rqikiwfqnrrmkwkk | HCID 16135911 | — |
| Edukt | TFA triisopropylsilane | HCID 131724268 | — |
| Edukt | HCID 178418600 | HCID 178418600 | — |
| Lösungsmittel | Dimethylformamide | HCID 6228 | — |
| Produkt | HCID 178512911 | HCID 178512911 | — |
Reaktionsschritte
General Procedure for Peptide Synthesis. Tat49-57 (RKKRRQRRR; SEQ ID NO:28), truncated and alanine-substituted peptides derived from Tat49-57, Antennapedia43-58 (RQIKIWFQNRRMKWKK; SEQ ID NO:29), and homopolymers of arginine (R5–R9; SEQ ID NO:1–5) and d-arginine (r5-r9) were prepared with an automated peptide synthesizer (ABI433) using standard solid-phase Fmoc chemistry (35) with HATU as the peptide coupling reagent. The fluorescein moiety was attached via a aminohexanoic acid spacer by treating a resin-bound peptide (1.0 mmol) with fluorescein isothiocyanate (1.0 mmol) and DIEA (5 mmol) in DMF (10 mL) for 12 h. Cleavage from the resin was achieved using 95:5 TFA/triisopropylsilane. Removal of the solvent in vacuo gave a crude oil which was triturated with cold ether. The crude mixture thus obtained was centrifuged, the ether was removed by decantation, and the resulting orange solid was purified by reverse-phase HPLC (H2O/CH3CN in 0.1% TFA). The products were isolated by lyophilization and characterized by electrospray mass spectrometry. Purity of the peptides was >95% as determined by analytical reverse-phase HPLC (H2O/CH3CN in 0.1% TFA).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US07229961B2 |
|---|
| Quelldatensatz | uspto-grants-2007_06 |
|---|
| ORD ID | ord-cdb09df517b6459b87b01e0005bfd423 |
|---|
| Quellennotiz | uspto-grants-2007_06 |
|---|